Hidden asymptomatic breakthrough infection in a proof-of-concept longitudinal study on SARS-CoV-2 vaccine recipients.

However, while the Netherlands cross-sectional study detected no statistical significance in anti-S Ab in their asymptomatic breakthrough infection [ 12 ], we used v7 -normalized v 8 sera ( v 8/ v 7) and detected here highly significant anti-S ++ (intermediate) levels in four out of four anti-S Ab assays in Taiwanese asymptomatic breakthrough infection (Fig. 4 b).

also in 132,142 other papers